New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
10:00 EDTFDO, SBAC, LSI, BIIB, STI, UNH, MS, ALTR, AMD, WAT, AFL, GEVA, LYB, CY, AOS, CCO, WLPOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: A.O. Smith (AOS) downgraded to Neutral from Buy at Janney Capital... AMD (AMD) downgraded to Underweight from Equal Weight at Barclays... Altera (ALTR) downgraded to Equal Weight from Overweight at Barclays... Biogen (BIIB) downgraded to Neutral from Overweight at Piper Jaffray... Cypress Semiconductor (CY) downgraded to Equal Weight from Overweight at Barclays... LSI Corp. (LSI) downgraded to Equal Weight from Overweight at Barclays... LyondellBasell (LYB) downgraded to Neutral from Buy at Citigroup... Morgan Stanley (MS) downgraded to Reduce from Neutral at SunTrust... SBA Communications (SBAC) downgraded to Neutral from Outperform at Macquarie... Synageva (GEVA) downgraded to Neutral from Overweight at Piper Jaffray... UnitedHealth (UNH) downgraded to Hold from Buy at Deutsche Bank... Wellpoint (WLP) downgraded to Hold from Buy at Deutsche Bank... Aflac (AFL) downgraded to Neutral from Overweight at JPMorgan... SunTrust (STI) downgraded to Market Perform from Outperform at Raymond James... Clear Channel Outdoor (CCO) downgraded to Underperform from Neutral at Wedbush... Waters (WAT) downgraded to Market Perform from Outperform at Leerink... Family Dollar (FDO) downgraded to Market Perform from Outperform at Raymond James.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
November 19, 2015
12:18 EDTUNHUnitedHealth volatility increases after lowering FY15 guidance
Subscribe for More Information
11:52 EDTALTRIntel sees Altera as accelerator of 'virtuous cycle'
Subscribe for More Information
10:58 EDTUNHAnalysts say possible exchange exit positive for battered UnitedHealth
The shares of health insurer UnitedHealth (UNH) and a number of other companies in the sector are falling after the Dow member lowered its fiscal 2015 profit guidance, citing weakness in individual health insurance policies it markets through exchanges. WHAT'S NEW: UnitedHealth lowered its fiscal 2015 earnings per share guidance to $6 from $6.25-$6.35. Analysts' consensus estimate was $6.31. The company identified policies sold to individuals through exchanges as the culprit. UnitedHealth said it expects to lose 26c per share on these policies in 2015 and 2016. The insurer stated that its other businesses were performing in-line with expectations and showing strength. UnitedHealth said it has pulled back on its marketing efforts for individual exchange products in 2016 and indicated that it would consider offering fewer individual policies through exchanges in 2017. UnitedHealth provided fiscal 2016 EPS guidance of $7.10-$7.30, versus the consensus outlook of $7.28. ANALYST REACTION: Any weakness in UnitedHealth and other health insurers today on the news from UnitedHealth creates a strong buying opportunity, Leerink Swann analyst Ana Gupte wrote in a note to investors today. The government will either reform the exchanges to make them more profitable for the insurers or they will exit the market, Gupte predicted. Moreover, the downside risk for health insurers Aetna (AET), Anthem (ANTM), Humana (HUM), and Cigna (CI) from today's news are low, since their Q3 and 2016 outlooks already incorporated the negative trends cited by UnitedHealth, the analyst stated. Mizuho Securities analyst Sheryl Skolnick was more cautious, predicting that the news would "rattle" the health insurance sector. United Health is more "insulated" than its peers from the weakness of the exchanges because its exposure to the market is relatively limited and its business is more diversified than that of its peers, according to Skolnick, who kept a $150 price target and Buy rating on the stock. Meanwhile, Piper Jaffray analyst Sean Wieland says UnitedHealth reducing its exchange exposure should be accretive to shareholder value. The company's participation in exchanges is not essential to its growth strategy, according to Wieland. The issues cited for the guidance cut likely applies to all Managed Care companies, therefore UnitedHealth should outperform peers given its limited exposure to exchanges, contends Wieland, who reiterated an Overweight rating on the stock with a $149 price target. PRICE ACTION: In morning trading, UnitedHealth fell 4% to $112.49, Aetna declined 4.4% to $102.18, Humana gave back 2.4% to $167, Anthem fell 6.6% to $128.20, and Cigna slid 3.8% to $130.
10:39 EDTUNHUnitedHealth growth not dependent on exchanges, says Piper Jaffray
Subscribe for More Information
10:23 EDTUNHUnitedHealth selloff on guidance presents buying opportunity, says Leerink
Subscribe for More Information
10:00 EDTUNHUnitedHealth pulls back on marketing efforts for individual exchange programs
UnitedHealthcare announced it has pulled back on its marketing efforts for individual exchange products in 2016. The company is evaluating the viability of the insurance exchange product segment and will determine during the first half of 2016 to what extent it can continue to serve the public exchange markets in 2017.
09:16 EDTUNHUnitedHealth falls on FY15 guidance
Subscribe for More Information
07:46 EDTUNHOptions expected to be active; UNH AET ANTM CI WCG HUM HNT CNC
Subscribe for More Information
06:40 EDTUNHUnitedHealth volatility flat into lowering FY15 guidance
Subscribe for More Information
06:11 EDTUNHUnitedHealth to host conference call
Subscribe for More Information
05:59 EDTUNHUnitedHealth cuts FY15 to $6.00 from $6.25-$6.35
Subscribe for More Information
05:57 EDTUNHUnitedHealth sees FY16 EPS $7.10-$7.30, consensus $7.28
Subscribe for More Information
November 18, 2015
15:40 EDTUNHCongressman says U.S. may need look at pharmacy competition, dealReporter says
Subscribe for More Information
13:44 EDTALTRBefore the Move: Watch Intel into tomorrow's analyst day
Chipmaker Intel's (INTC) analyst day tomorrow could yield information on numerous company operations, but Jefferies analyst Mark Lipacis cautions investors that the probability for positive surprises appears low given recent spending outlays. BACKGROUND: Intel, one of the largest semiconductor makers in the world, is scheduled to hold an analyst day on Thursday, November 19. Beyond providing forecasts for its various business segments and remarks on the larger computer market, Intel is expected to provide further clarity on several recent stories, including its memory joint venture with Micron (MU), plans to invest heavily in a Chinese production facility and progression towards chips on the 10 nanometer scale. STRONG OUTLOOK, MILD MEETING: Intel's pending acquisition of Altera (ALTR) and its plans to invest as much as $5.5B in a computer memory facility in Dalian, China leave little room for positive surprises at tomorrow's event in regards to 2016 margins, capital expenditures, or shareholder returns, Jefferies analyst Mark Lipacis said in a recent research note. That said, the analyst views Intel's Chinese facility expansion as part of a "brilliant investment strategy that positions Intel as a partner to China" and "keeps the market open" to its microprocessors, perhaps Intel's more famed business segment. Though the two initiatives are certain to push up near-term debt load, Lipacis takes the longer-term view, reminding investors that Intel has shown consistently strong free cash flow over the past decade, leading him to forecast another $13B in 2016. The year may also bring "a number" of other positives for the company, including more data center wins after the Altera tie-up, potentially renewed sales on a cyclical uptick in PC gaming, and even the possibility of an iPhone chip contract, though Lipacis said none of those points look set to be discussed tomorrow. The analyst kept a Buy rating and $38 price target on the shares while reiterating that Thursday's Intel event may have little in store for those expecting eye-grabbing surprises. PRICE ACTION: Shares of Intel have advanced roughly 0.9% to $32.92 Wednesday afternoon. "Before the Move" is The Fly's recurring series of exclusive stories that identify potentially market moving events, along with analyst predictions, ahead of the news.
08:55 EDTMSMorgan Stanley exec sees Q4 not much better than Q3 for banks, DJ reports
Morgan Stanley (MS) Institutional Securities President Colm Kelleher cautioned that fixed-income markets "still seem subdued," according to Dow Jones, citing his comments at an investment conference. Morgan Stanley was among the banks that reported lower revenue from fixed-income, currency and commodities trading during the third quarter and Kelleher said he doesn't think "the fourth quarter is going to be much better," the report noted. Large bank peers to Morgan Stanley include Bank of America (BAC), Citi (C), Goldman Sachs (GS), JPMorgan (JPM), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
November 17, 2015
09:44 EDTMSBrookings Institute to hold a discussion
The Hutchins Center on Fiscal and Monetary Policy at Brookings and Ben Bernanke host a discussion with Betsy Graseck of Morgan Stanley, Governor Tarullo of the Federal Reserve on the role of collateral in the financial system, liquidity in bond markets and the shadow banking system in a meeting being held in Washington, D.C. on November 17 at 1:30 pm. Webcast Link
09:05 EDTUNHOptumRx acquires AxelaCare
Subscribe for More Information
08:04 EDTWATStifel to hold a conference
Subscribe for More Information
07:56 EDTCYUBS to hold a conference
Global Technology Conference is being held in San Francisco on November 16-18 with webcasted company presentations to begin on November 17 at 10:45 am.; not all company presentations may be webcasted. Webcast Link
07:48 EDTSTI, MSBofa/Merrill to hold a conference
Banking & Financial Services Conference 2015 is being held in New York on November 17-18.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use